Cost-benefit Analysis of Breast Cancer Screening with Digital Mammography: A Systematic Review.
Breast Cancer
Cost-Benefit Analysis
Mammography
Systematic Review
Journal
Medical journal of the Islamic Republic of Iran
ISSN: 1016-1430
Titre abrégé: Med J Islam Repub Iran
Pays: Iran
ID NLM: 8910777
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
08
2022
medline:
26
9
2023
pubmed:
26
9
2023
entrez:
26
9
2023
Statut:
epublish
Résumé
Breast cancer is a non-communicable and common disease that accounts for a high percentage of deaths. Early diagnosis of this disease reduces the death rate. Screening methods such as digital mammography can help prevent or identify the disease earlier. Therefore, this study aims to analyze the cost-benefit of breast cancer using digital mammography. This systematic review was conducted based on PRISMA 2020 checklist. PubMed, Scopus, Web of Science, ProQuest, Cochrane Library, and Google Scholar were searched without any time limitation on June 2022. The quality of the studies was evaluated with the CHEERS checklist. After data extraction, the results were synthesized by thematic content analysis. During the search, 3468 records were identified, of which 1061 were duplicates. 2407 titles and abstracts screened in terms of inclusion criteria. Finally, after studying 20 fulltexts, three of them were included in the study. The quality of these articles was scored between 10 and 16. These studies were from Spain, Denmark, and the United States from 2000 to 2019. Two studies showed that digital mammography is not as effective as other screening methods. The results of this study showed that digital mammography is not very cost-benefit for the health care system. An increase in its repetition frequency imposes more costs on the health system and doesn't have more benefits for it.
Sections du résumé
Background
UNASSIGNED
Breast cancer is a non-communicable and common disease that accounts for a high percentage of deaths. Early diagnosis of this disease reduces the death rate. Screening methods such as digital mammography can help prevent or identify the disease earlier. Therefore, this study aims to analyze the cost-benefit of breast cancer using digital mammography.
Methods
UNASSIGNED
This systematic review was conducted based on PRISMA 2020 checklist. PubMed, Scopus, Web of Science, ProQuest, Cochrane Library, and Google Scholar were searched without any time limitation on June 2022. The quality of the studies was evaluated with the CHEERS checklist. After data extraction, the results were synthesized by thematic content analysis.
Results
UNASSIGNED
During the search, 3468 records were identified, of which 1061 were duplicates. 2407 titles and abstracts screened in terms of inclusion criteria. Finally, after studying 20 fulltexts, three of them were included in the study. The quality of these articles was scored between 10 and 16. These studies were from Spain, Denmark, and the United States from 2000 to 2019. Two studies showed that digital mammography is not as effective as other screening methods.
Conclusion
UNASSIGNED
The results of this study showed that digital mammography is not very cost-benefit for the health care system. An increase in its repetition frequency imposes more costs on the health system and doesn't have more benefits for it.
Identifiants
pubmed: 37750094
doi: 10.47176/mjiri.37.89
pmc: PMC10518066
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
89Informations de copyright
© 2023 Iran University of Medical Sciences.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Breast Cancer Res Treat. 2007 Jan;101(1):59-64
pubmed: 16821083
Ann Intern Med. 2008 Jan 1;148(1):1-10
pubmed: 18166758
PLoS One. 2018 Jun 7;13(6):e0197891
pubmed: 29879136
BMC Health Serv Res. 2009 Jan 13;9:9
pubmed: 19144138
BMC Health Serv Res. 2017 Jan 26;17(1):84
pubmed: 28122558
PLoS One. 2018 Mar 26;13(3):e0194996
pubmed: 29579131
Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):653-660
pubmed: 33531436
Int J Technol Assess Health Care. 2013 Apr;29(2):117-22
pubmed: 23587340
Breast Cancer Res Treat. 2017 Jul;164(2):429-436
pubmed: 28432514
Syst Rev. 2021 Jan 26;10(1):39
pubmed: 33499930
Ann Med Surg (Lond). 2019 Jul 10;44:87-90
pubmed: 31341618
Ann Intern Med. 2022 Jan;175(1):11-19
pubmed: 34807717
Asia Pac J Clin Oncol. 2018 Jun;14(3):167-178
pubmed: 28670694
Cancer Epidemiol. 2015 Aug;39(4):519-27
pubmed: 26070507
PLoS One. 2014 Feb 03;9(2):e86858
pubmed: 24498285
Biomed Pharmacother. 2019 Nov;119:109414
pubmed: 31518875
Breast J. 2007 Nov-Dec;13(6):571-4
pubmed: 17983398
Ann Intern Med. 2011 Jul 5;155(1):10-20
pubmed: 21727289
J Magn Reson Imaging. 2019 Jun;49(7):e216-e221
pubmed: 30632645
Int J Technol Assess Health Care. 2000 Summer;16(3):811-21
pubmed: 11028136
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593